{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "bioactive", "bitter melon (M. charantia)", "glucose-lowering effects", "hypoglycemic", "medicinal plants", "natural", "neuroprotective", "prevalence", "therapeutic", "type 2 diabetes mellitus"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36902074", "DateCompleted": {"Year": "2023", "Month": "04", "Day": "10"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["4643", "10.3390/ijms24054643"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "5", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "28"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "The Effects of <i>Momordica charantia</i> on Type 2 Diabetes Mellitus and Alzheimer's Disease.", "Abstract": {"AbstractText": ["T2DM is a complex metabolic disorder characterized by hyperglycemia and glucose intolerance. It is recognized as one of the most common metabolic disorders and its prevalence continues to raise major concerns in healthcare globally. Alzheimer's disease (AD) is a gradual neurodegenerative brain disorder characterized by the chronic loss of cognitive and behavioral function. Recent research suggests a link between the two diseases. Considering the shared characteristics of both diseases, common therapeutic and preventive agents are effective. Certain bioactive compounds such as polyphenols, vitamins, and minerals found in vegetables and fruits can have antioxidant and anti-inflammatory effects that allow for preventative or potential treatment options for T2DM and AD. Recently, it has been estimated that up to one-third of patients with diabetes use some form of complementary and alternative medicine. Increasing evidence from cell or animal models suggests that bioactive compounds may have a direct effect on reducing hyperglycemia, amplifying insulin secretion, and blocking the formation of amyloid plaques. One plant that has received substantial recognition for its numerous bioactive properties is <i>Momordica charantia (M. charantia)</i>, otherwise known as bitter melon, bitter gourd, karela, and balsam pear. <i>M. charantia</i> is utilized for its glucose-lowering effects and is often used as a treatment for diabetes and related metabolic conditions amongst the indigenous populations of Asia, South America, India, and East Africa. Several pre-clinical studies have documented the beneficial effects of <i>M. charantia</i> through various postulated mechanisms. Throughout this review, the underlying molecular mechanisms of the bioactive components of <i>M. charantia</i> will be highlighted. More studies will be necessary to establish the clinical efficacy of the bioactive compounds within <i>M. charantia</i> to effectively determine its pertinence in the treatment of metabolic disorders and neurodegenerative diseases, such as T2DM and AD."]}, "AuthorList": [{"Identifier": ["0009-0009-5867-5231"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA."}], "LastName": "Richter", "ForeName": "Erika", "Initials": "E"}, {"Identifier": ["0000-0001-6358-0012"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA."}, {"Identifier": [], "Affiliation": "Boshell Metabolic Diseases and Diabetes Program, Auburn University, Auburn, AL 36849, USA."}], "LastName": "Geetha", "ForeName": "Thangiah", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA."}, {"Identifier": [], "Affiliation": "Boshell Metabolic Diseases and Diabetes Program, Auburn University, Auburn, AL 36849, USA."}], "LastName": "Burnett", "ForeName": "Donna", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Laboratory of Diabetes and Exercise Metabolism, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USA."}], "LastName": "Broderick", "ForeName": "Tom L", "Initials": "TL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA."}, {"Identifier": [], "Affiliation": "Boshell Metabolic Diseases and Diabetes Program, Auburn University, Auburn, AL 36849, USA."}], "LastName": "Babu", "ForeName": "Jeganathan Ramesh", "Initials": "JR"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hyperglycemia"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Momordica charantia"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Marras C., Beck J.C., Bower J.H., Roberts E., Ritz B., Ross G.W., Abbott R.D., Savica R., Van Den Eeden S.K., Willis A.W., et al. Prevalence of parkinson\u2019s disease across North America. NPJ Parkinson\u2019s Dis. 2018;4:21. doi: 10.1038/s41531-018-0058-0.", "ArticleIdList": ["10.1038/s41531-018-0058-0", "PMC6039505", "30003140"]}, {"Citation": "Leung L., Birtwhistle R., Kotecha J., Hannah S., Cuthbertson S. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): A mini review. Br. J. Nutr. 2009;102:1703\u20131708. doi: 10.1017/S0007114509992054.", "ArticleIdList": ["10.1017/S0007114509992054", "19825210"]}, {"Citation": "Joseph B., Jini D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Dis. 2013;3:93\u2013102. doi: 10.1016/S2222-1808(13)60052-3.", "ArticleIdList": ["10.1016/S2222-1808(13)60052-3"]}, {"Citation": "Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiol. Rev. 2013;93:137\u2013188. doi: 10.1152/physrev.00045.2011.", "ArticleIdList": ["10.1152/physrev.00045.2011", "23303908"]}, {"Citation": "Centers for Disease Control and Prevention  What Is Alzheimer\u2019s Disease? Centers for Disease Control and Prevention.  [(accessed on 16 January 2023)];2020  Available online:  https://www.cdc.gov/aging/aginginfo/alzheimers.htm."}, {"Citation": "WebMD. (n.d.)  WebMD Diabetes Center: Types, Causes, Symptoms, Tests, and Treatments. WebMD.  [(accessed on 16 January 2023)].  Available online:  https://www.webmd.com/diabetes/peripheral-neuropathy-risk-factors-symptoms#1."}, {"Citation": "Akter K., Lanza E.A., Martin S.A., Myronyuk N., Rua M., Raffa R.B. Diabetes mellitus and Alzheimer\u2019s disease: Shared pathology and treatment? Br. J. Clin. Pharmacol. 2011;71:365\u2013376. doi: 10.1111/j.1365-2125.2010.03830.x.", "ArticleIdList": ["10.1111/j.1365-2125.2010.03830.x", "PMC3045545", "21284695"]}, {"Citation": "Mayo Foundation for Medical Education and Research  Alzheimer\u2019s Disease. Mayo Clinic. 2022.  [(accessed on 5 November 2022)].  Available online:  https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptomscauses/syc-20350447."}, {"Citation": "U.S. Department of Health and Human Services. (n.d.)  Alzheimer\u2019s Disease Fact Sheet. National Institute on Aging.  [(accessed on 16 January 2023)]; Available online:  https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet."}, {"Citation": "Mohammed S.A., Yaqub A.G., Sanda K.A., Nicholas A.O., Arastus W., Muhammad M. Review on diabetes, synthetic drugs and glycemic effects of medicinal plants. J. Med. Plants Res. 2013;7:2628\u20132637."}, {"Citation": "Ma T., Tan M.-S., Yu J.-T., Tan L. Resveratrol as a therapeutic agent for Alzheimer\u2019s disease. BioMed Res. Int. 2014;2014:350516. doi: 10.1155/2014/350516.", "ArticleIdList": ["10.1155/2014/350516", "PMC4261550", "25525597"]}, {"Citation": "Walker J., Harrison F. Shared neuropathological characteristics of obesity, type 2 diabetes and Alzheimer\u2019s disease: Impacts on cognitive decline. Nutrients. 2015;7:7332\u20137357. doi: 10.3390/nu7095341.", "ArticleIdList": ["10.3390/nu7095341", "PMC4586536", "26340637"]}, {"Citation": "De la Monte S.M., Wands J.R. Alzheimer\u2019s disease is type 3 diabetes\u2014Evidence reviewed. J. Diabetes Sci. Technol. 2008;2:1101\u20131113. doi: 10.1177/193229680800200619.", "ArticleIdList": ["10.1177/193229680800200619", "PMC2769828", "19885299"]}, {"Citation": "Venkata Raman B., Vamsikrishna A., Rao B., Pudha M., Saradhi M.V., Rao B. Plants with antidiabetic activities and their medicinal values. Int. Res. J. Pharm. 2012;3:11\u201315."}, {"Citation": "Gothai S., Ganesan P., Park S.-Y., Fakurazi S., Choi D.-K., Arulselvan P. Natural phyto-bioactive compounds for the treatment of type 2 diabetes: Inflammation as a target. Nutrients. 2016;8:461. doi: 10.3390/nu8080461.", "ArticleIdList": ["10.3390/nu8080461", "PMC4997374", "27527213"]}, {"Citation": "Cefalu W., Ye J., Wang Z. Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocr. Metab. Immune Disord.-Drug Targets. 2008;8:78\u201381. doi: 10.2174/187153008784534376.", "ArticleIdList": ["10.2174/187153008784534376", "18537692"]}, {"Citation": "Cousens G., Rainoshek D. There Is a Cure for Diabetes: The Tree of Life 21-Day+ Program. North Atlantic Books; Berkeley, CA, USA: 2008."}, {"Citation": "McAnany B., Martirosyan D. The effects of bioactive compounds on Alzheimer\u2019s disease and mild cognitive impairment. Funct. Foods Health Dis. 2016;6:329. doi: 10.31989/ffhd.v6i6.257.", "ArticleIdList": ["10.31989/ffhd.v6i6.257"]}, {"Citation": "Mayo Foundation for Medical Education and Research  . Type 2 Diabetes. Mayo Clinic; Scottsdale, AZ, USA: 2021.  [(accessed on 5 November 2022)].  Available online:  https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/symptoms-causes/syc-20351193."}, {"Citation": "Mahler R.J., Adler M.L. Type 2 diabetes mellitus: Update on diagnosis, pathophysiology, and treatment. J. Clin. Endocrinol. Metab. 1999;84:1165\u20131171. doi: 10.1210/jcem.84.4.5612.", "ArticleIdList": ["10.1210/jcem.84.4.5612", "10199747"]}, {"Citation": "Sen S., Chakraborty R., De B. Diabetes Mellitus in 21st Century. Springer; Singapore: 2016. Pancreatic hormones and control of blood glucose: A glance; pp. 1\u201312.", "ArticleIdList": ["10.1007/978-981-10-1542-7_1"]}, {"Citation": "Gelding S.V., Coldham N., Niththyananthan R., Anyaoku V., Johnston D.G. Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes. Diabet. Med. 1995;12:66\u201373. doi: 10.1111/j.1464-5491.1995.tb02065.x.", "ArticleIdList": ["10.1111/j.1464-5491.1995.tb02065.x", "7712708"]}, {"Citation": "Charles M.A., Eschwe\u2019ge E., Thibult N., Claude J.-R., Warnet J.-M., Rosselin G.E., Girard J., Balkau B. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris Prospective Study. Diabetologia. 1997;40:1101\u20131106. doi: 10.1007/s001250050793.", "ArticleIdList": ["10.1007/s001250050793", "9300248"]}, {"Citation": "Kitamura T. The role of FOXO1 in \u03b2-cell failure and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2013;9:615\u2013623. doi: 10.1038/nrendo.2013.157.", "ArticleIdList": ["10.1038/nrendo.2013.157", "23959366"]}, {"Citation": "Fischbach S. The role of TGF-\u03b2 signaling in \u03b2-cell dysfunction and type 2 diabetes: A Review. J. Cytol. Histol. 2014;5:1000282. doi: 10.4172/2157-7099.1000282.", "ArticleIdList": ["10.4172/2157-7099.1000282"]}, {"Citation": "Li R., Zhang Y., Rasool S., Geetha T., Babu J.R. Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer\u2019s Disease. Oxidative Med. Cell. Longev. 2019;2019:8165707. doi: 10.1155/2019/8165707.", "ArticleIdList": ["10.1155/2019/8165707", "PMC6360036", "30800211"]}, {"Citation": "Granzotto A., Zatta P. Resveratrol and Alzheimer\u2019s disease: Message in a bottle on red wine and cognition. Front. Aging Neurosci. 2014;6:95. doi: 10.3389/fnagi.2014.00095.", "ArticleIdList": ["10.3389/fnagi.2014.00095", "PMC4030174", "24860502"]}, {"Citation": "Desai G.S., Zheng C., Geetha T., Mathews S.T., White B.D., Huggins K.W., Zizza C.A., Broderick T.L., Babu J.R. The pancreas-brain axis: Insight into disrupted mechanisms associating type 2 diabetes and Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2014;42:347\u2013356. doi: 10.3233/JAD-140018.", "ArticleIdList": ["10.3233/JAD-140018", "24858405"]}, {"Citation": "Querfurth H.W., LaFerla F.M. Alzheimer\u2019s disease. New Engl. J. Med. 2010;362:329\u2013344. doi: 10.1056/NEJMra0909142.", "ArticleIdList": ["10.1056/NEJMra0909142", "20107219"]}, {"Citation": "Bharadwaj P.R., Dubey A.K., Masters C.L., Martins R.N., Macreadie I.G. AB aggregation and possible implications in Alzheimer\u2019s disease pathogenesis. J. Cell. Mol. Med. 2009;13:412\u2013421. doi: 10.1111/j.1582-4934.2009.00609.x.", "ArticleIdList": ["10.1111/j.1582-4934.2009.00609.x", "PMC3822505", "19374683"]}, {"Citation": "Finder V.H., Glockshuber R. Amyloid-\u03b2 aggregation. Neurodegener. Dis. 2007;4:13\u201327. doi: 10.1159/000100355.", "ArticleIdList": ["10.1159/000100355", "17429215"]}, {"Citation": "De la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer\u2019s disease. J. Alzheimers Dis. 2005;7:45\u201361. doi: 10.3233/JAD-2005-7106.", "ArticleIdList": ["10.3233/JAD-2005-7106", "15750214"]}, {"Citation": "Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014Is this type 3 diabetes? J. Alzheimers Dis. 2005;7:63\u201380. doi: 10.3233/JAD-2005-7107.", "ArticleIdList": ["10.3233/JAD-2005-7107", "15750215"]}, {"Citation": "De la Monte S.M., Wands J.R. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer\u2019s disease. J. Alzheimers Dis. 2006;9:167\u2013181. doi: 10.3233/JAD-2006-9209.", "ArticleIdList": ["10.3233/JAD-2006-9209", "16873964"]}, {"Citation": "Moreira P.I., Santos M.S., Sei\u00e7a R., Oliveira C.R. Brain mitochondrial dysfunction as a link between Alzheimer\u2019s disease and diabetes. J. Neurol. Sci. 2007;257:206\u2013214. doi: 10.1016/j.jns.2007.01.017.", "ArticleIdList": ["10.1016/j.jns.2007.01.017", "17316694"]}, {"Citation": "Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: An update. J. Neural Transm. 2002;109:341\u2013360. doi: 10.1007/s007020200028.", "ArticleIdList": ["10.1007/s007020200028", "11956956"]}, {"Citation": "Nixon R.A. The calpains in aging and aging-related diseases. Ageing Res. Rev. 2003;2:407\u2013418. doi: 10.1016/S1568-1637(03)00029-1.", "ArticleIdList": ["10.1016/S1568-1637(03)00029-1", "14522243"]}, {"Citation": "Rivera E.J., Goldin A., Fulmer N., Tavares R., Wands J.R., de la Monte S.M. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: Link to brain reductions in acetylcholine. J. Alzheimers Dis. 2005;8:247\u2013268. doi: 10.3233/JAD-2005-8304.", "ArticleIdList": ["10.3233/JAD-2005-8304", "16340083"]}, {"Citation": "Revill P., Moral M.A., Prous J.R. Impaired insulin signaling and the pathogenesis of Alzheimer\u2019s disease. Drugs Today. 2006;42:785\u2013790. doi: 10.1358/dot.2006.42.12.1032059.", "ArticleIdList": ["10.1358/dot.2006.42.12.1032059", "17285151"]}, {"Citation": "Iwangoff P., Armbruster R., Enz A., Meier-Ruge W. Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases. Mech. Ageing Dev. 1980;14:203\u2013209. doi: 10.1016/0047-6374(80)90120-7.", "ArticleIdList": ["10.1016/0047-6374(80)90120-7", "6259457"]}, {"Citation": "Sims N.R., Bowen D.M., Smith C.C., Flack R.H., Davison A.N., Snowden J.S., Neary D. Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer\u2019s disease. Lancet. 1980;315:333\u2013336. doi: 10.1016/S0140-6736(80)90884-3.", "ArticleIdList": ["10.1016/S0140-6736(80)90884-3", "6101790"]}, {"Citation": "Hoyer S. Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: Therapeutic implications. Adv. Exp. Med. Biol. 2004;541:135\u2013152.", "ArticleIdList": ["14977212"]}, {"Citation": "Li X., Leng S., Song D. Link between type 2 diabetes and Alzheimer\u2019s disease: From epidemiology to mechanism and treatment. Clin. Interv. Aging. 2015;10:549\u2013560. doi: 10.2147/CIA.S74042.", "ArticleIdList": ["10.2147/CIA.S74042", "PMC4360697", "25792818"]}, {"Citation": "Li L., H\u00f6lscher C. Common pathological processes in alzheimer disease and type 2 diabetes: A Review. Brain Res. Rev. 2007;56:384\u2013402. doi: 10.1016/j.brainresrev.2007.09.001.", "ArticleIdList": ["10.1016/j.brainresrev.2007.09.001", "17920690"]}, {"Citation": "Braak H., Braak E. Staging of alzheimer-related cortical destruction. Int. Psychogeriatr. 1997;9:257\u2013261. doi: 10.1017/S1041610297004973.", "ArticleIdList": ["10.1017/S1041610297004973", "9447446"]}, {"Citation": "Phiel C.J., Wilson C.A., Lee V.M.-Y., Klein P.S. GSK-3\u03b1 regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides. Nature. 2003;423:435\u2013439. doi: 10.1038/nature01640.", "ArticleIdList": ["10.1038/nature01640", "12761548"]}, {"Citation": "Bomfim T.R., Forny-Germano L., Sathler L.B., Brito-Moreira J., Houzel J.-C., Decker H., Silverman M.A., Kazi H., Melo H.M., McClean P.L., et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease\u2013associated A\u0392 oligomers. J. Clin. Investig. 2012;122:1339\u20131353. doi: 10.1172/JCI57256.", "ArticleIdList": ["10.1172/JCI57256", "PMC3314445", "22476196"]}, {"Citation": "Kurochkin I.V., Goto S. Alzheimer\u2019s \u03b2-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 1994;345:33\u201337. doi: 10.1016/0014-5793(94)00387-4.", "ArticleIdList": ["10.1016/0014-5793(94)00387-4", "8194595"]}, {"Citation": "Mirza S., Hossain M., Mathews C., Martinez P., Pino P., Gay J.L., Rentfro A., McCormick J.B., Fisher-Hoch S.P. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: A cross-sectional study. Cytokine. 2012;57:136\u2013142. doi: 10.1016/j.cyto.2011.09.029.", "ArticleIdList": ["10.1016/j.cyto.2011.09.029", "PMC3270578", "22035595"]}, {"Citation": "Spranger J., Kroke A., M\u00f6hlig M., Hoffmann K., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F.H. Inflammatory cytokines and the risk to develop type 2 diabetes. Diabetes. 2003;52:812\u2013817. doi: 10.2337/diabetes.52.3.812.", "ArticleIdList": ["10.2337/diabetes.52.3.812", "12606524"]}, {"Citation": "Palmer J.P., Helqvist S., Spinas G.A., M\u00f8lvig J., Mandrup-Poulsen T., Andersen H.U., Nerup J. Interaction of \u03b2-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes. 1989;38:1211\u20131216. doi: 10.2337/diab.38.10.1211.", "ArticleIdList": ["10.2337/diab.38.10.1211", "2676656"]}, {"Citation": "Banks W. Blood-brain barrier transport of cytokines: A mechanism for neuropathology. Curr. Pharm. Des. 2005;11:973\u2013984. doi: 10.2174/1381612053381684.", "ArticleIdList": ["10.2174/1381612053381684", "15777248"]}, {"Citation": "Taepavarapruk P., Song C. Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1\u03b2 administrations: Effects of omega-3 fatty acid EPA treatment. J. Neurochem. 2010;112:1054\u20131064. doi: 10.1111/j.1471-4159.2009.06524.x.", "ArticleIdList": ["10.1111/j.1471-4159.2009.06524.x", "19968753"]}, {"Citation": "Goh S.-Y., Cooper M.E. The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 2008;93:1143\u20131152. doi: 10.1210/jc.2007-1817.", "ArticleIdList": ["10.1210/jc.2007-1817", "18182449"]}, {"Citation": "Abate G., Marziano M., Rungratanawanich W., Memo M., Uberti D. Nutrition and age-ing: Focusing on Alzheimer\u2019s disease. Oxidative Med. Cell. Longev. 2017;2017:7039816. doi: 10.1155/2017/7039816.", "ArticleIdList": ["10.1155/2017/7039816", "PMC5266861", "28168012"]}, {"Citation": "Chaney M.O., Stine W.B., Kokjohn T.A., Kuo Y.-M., Esh C., Rahman A., Luehrs D.C., Schmidt A.M., Stern D., Yan S.D., et al. Rage and amyloid beta interactions: Atomic force microscopy and Molecular Modeling. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2005;1741:199\u2013205. doi: 10.1016/j.bbadis.2005.03.014.", "ArticleIdList": ["10.1016/j.bbadis.2005.03.014", "15882940"]}, {"Citation": "Deane R., Zlokovic B. Role of the blood-brain barrier in the pathogenesis of alzheimers disease. Curr. Alzheimer Res. 2007;4:191\u2013197. doi: 10.2174/156720507780362245.", "ArticleIdList": ["10.2174/156720507780362245", "17430246"]}, {"Citation": "Matrone C., Djelloul M., Taglialatela G., Perrone L. Inflammatory risk factors and pathologies promoting Alzheimer\u2019s disease progression: Is RAGE the key? Histol. Histopathol. 2015;30:125\u2013139.", "ArticleIdList": ["25014735"]}, {"Citation": "Reddy V.P., Zhu X., Perry G., Smith M.A. Oxidative stress in diabetes and Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2009;16:763\u2013774. doi: 10.3233/JAD-2009-1013.", "ArticleIdList": ["10.3233/JAD-2009-1013", "PMC2765716", "19387111"]}, {"Citation": "Nita M., Grzybowski A. The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxidative Med. Cell. Longev. 2016;2016:3164734. doi: 10.1155/2016/3164734.", "ArticleIdList": ["10.1155/2016/3164734", "PMC4736974", "26881021"]}, {"Citation": "Ahmad W., Ijaz B., Shabbiri K., Ahmed F., Rehman S. Oxidative toxicity in diabetes and Alzheimer\u2019s disease: Mechanisms behind ROS/RNS generation. J. Biomed. Sci. 2017;24:76. doi: 10.1186/s12929-017-0379-z.", "ArticleIdList": ["10.1186/s12929-017-0379-z", "PMC5606025", "28927401"]}, {"Citation": "Galanakis C.M. Nutraceutical and Functional Food Components. Academic Press; Cambridge, MA, USA: 2017."}, {"Citation": "Huang T.-C., Lu K.-T., Wo Y.-Y.P., Wu Y.-J., Yang Y.-L. Resveratrol protects rats from A\u0392-induced neurotoxicity by the reduction of inos expression and lipid peroxidation. PLoS ONE. 2011;6:e0029102. doi: 10.1371/journal.pone.0029102.", "ArticleIdList": ["10.1371/journal.pone.0029102", "PMC3248406", "22220203"]}, {"Citation": "Mahmoud M.F., Hassan N.A., El Bassossy H.M., Fahmy A. Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: Effect on low grade inflammation. PLoS ONE. 2013;8:e0063784. doi: 10.1371/journal.pone.0063784.", "ArticleIdList": ["10.1371/journal.pone.0063784", "PMC3661670", "23717483"]}, {"Citation": "Jia S., Shen M., Zhang F., Xie J. Recent Advances in Momordica charantia: Functional Components and Biological Activities. Int. J. Mol. Sci. 2017;18:2555. doi: 10.3390/ijms18122555.", "ArticleIdList": ["10.3390/ijms18122555", "PMC5751158", "29182587"]}, {"Citation": "Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 2002;81:81\u2013100. doi: 10.1016/S0378-8741(02)00059-4.", "ArticleIdList": ["10.1016/S0378-8741(02)00059-4", "12020931"]}, {"Citation": "Teoh S.L., Latiff A.A., Das S. The effect of topical extract of Momordica charantia (bitter gourd) on wound healing in nondiabetic rats and in rats with diabetes induced by streptozotocin. Clin. Exp. Dermatol. 2009;34:815\u2013822. doi: 10.1111/j.1365-2230.2008.03117.x.", "ArticleIdList": ["10.1111/j.1365-2230.2008.03117.x", "19508570"]}, {"Citation": "Grover J.K., Yadav S.P. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol. 2004;93:123\u2013132. doi: 10.1016/j.jep.2004.03.035.", "ArticleIdList": ["10.1016/j.jep.2004.03.035", "15182917"]}, {"Citation": "Prasad V., Jain V., Girish D., Dorle A.K. Wound-healing property of Momordica charantia L. fruit powder. J. Hreb. Pharmacother. 2006;6:105\u2013115. doi: 10.1080/J157v06n03_05.", "ArticleIdList": ["10.1080/J157v06n03_05", "17317652"]}, {"Citation": "Raman A., Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae) Phytomedicine. 1996;2:349\u2013362. doi: 10.1016/S0944-7113(96)80080-8.", "ArticleIdList": ["10.1016/S0944-7113(96)80080-8", "23194773"]}, {"Citation": "Joseph B., Jini D. Insight into the hypoglycaemic effect of traditional Indian herbs used in the treatment of diabetes. Res. J. Med. Plant. 2011;5:352\u2013376. doi: 10.3923/rjmp.2011.352.376.", "ArticleIdList": ["10.3923/rjmp.2011.352.376"]}, {"Citation": "Joseph B., Jini D. A medicinal potency of Capparis decidua\u2013a harsh terrain plant. Res. J. Phytochem. 2011;5:1\u201313. doi: 10.3923/rjphyto.2011.1.13.", "ArticleIdList": ["10.3923/rjphyto.2011.1.13"]}, {"Citation": "Ayodhya S., Kusum S., Anjali S. Hypoglycaemic activity of different extracts of various herbal plants. IJRAP. 2010;1:212\u2013224."}, {"Citation": "Malviya N., Jain S., Malviya S. Anti-diabetic potential of medicinal plants. Acta Pol. Pharm. 2010;67:113\u2013118.", "ArticleIdList": ["20369787"]}, {"Citation": "Patel P., Harde P., Pillai J., Darji N., Patel B. Antidiabetic herbal drugs a review. Pharmacophore. 2012;3:18\u201329."}, {"Citation": "Kavishankar G.B., Lakshmidevi N., Murthy S.M., Prakash H.S., Niranjana S.R. Diabetes and medicinal plants-A review. Int. J. Pharm. Biomed Sci. 2011;2:65\u201380."}, {"Citation": "Hui H., Tang G., Liang V.W., Go V.L.W. Hypoglycemic herbs and their action mechanisms. Chin. Med. 2009;4:11\u201314. doi: 10.1186/1749-8546-4-11.", "ArticleIdList": ["10.1186/1749-8546-4-11", "PMC2704217", "19523223"]}, {"Citation": "Bakare R.I., Magbagbeola O.A., Akinwande A.I., Okunowo O.W. Nutritional and chemical evaluation of Momordica charantia. J. Med. Plant Res. 2010;4:2189\u20132193."}, {"Citation": "Islam S., Jalaluddin M., Hettiarachchy N.S. Bio-active compounds of bitter melon genotypes (Momordica charantia L.) in relation to their physiological functions. Funct. Foods Health Dis. 2011;1:61\u201374. doi: 10.31989/ffhd.v1i2.139.", "ArticleIdList": ["10.31989/ffhd.v1i2.139"]}, {"Citation": "Snee L.S., Nerurkar V.R., Dooley D.A., Efird J.T., Shovic A.C., Nerurkar P.V. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management. Nutr. J. 2011;10:78. doi: 10.1186/1475-2891-10-78.", "ArticleIdList": ["10.1186/1475-2891-10-78", "PMC3162490", "21794176"]}, {"Citation": "Saeed M.K., Shahzadi I., Ahmad I., Ahmad R., Shahzad K., Ashraf M. Viqar-un-Nisa. Nutritional analysis and antioxidant activity of bitter gourd (Momordica charantia) from Pakistan. Pharmacologyonline. 2010;1:252\u2013260."}, {"Citation": "Budrat P., Shotipruk A. Extraction of phenolic compounds from fruits of bitter melon (Momordica charantia) with subcritical water extraction and antioxidant activities of these extracts. Chiang Mai J. Sci. 2008;35:123\u2013130."}, {"Citation": "Chang C.I., Chen C.R., Liao Y.W., Cheng H.L., Chen Y.C., Chou C.H. Cucurbitane-type triterpenoids from Momordica charantia. J. Nat. Prod. 2006;71:1327\u20131330. doi: 10.1021/np070532u.", "ArticleIdList": ["10.1021/np070532u", "18637688"]}, {"Citation": "Tayyab F., Lal S.S., Mishra M., Kumar U. A review: Medicinal plants and its impact on diabetes. World J. Pharm Res. 2012;1:1019\u20131046."}, {"Citation": "Puri M., Kaur I., Kanwar R.K., Gupta R.C., Chauhan A., Kanwar J.R. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr. Mol. Med. 2009;9:1080\u20131094. doi: 10.2174/156652409789839071.", "ArticleIdList": ["10.2174/156652409789839071", "19747115"]}, {"Citation": "Fang E.F., Zhang C.Z.Y., Wong J.H., Shen J.Y., Li C.H., Ng T.B. The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo. Cancer Lett. 2012;324:66\u201374. doi: 10.1016/j.canlet.2012.05.005.", "ArticleIdList": ["10.1016/j.canlet.2012.05.005", "22579806"]}, {"Citation": "Pu Z., Lu B.Y., Liu W.Y., Jin S.W. Characterization of the enzymatic mechanism of \u03b3-momorcharin, a novel ribosome-inactivating protein with lower molecular weight of 11,500 purified from the seeds of bitter gourd (Momordica charantia) Biochem. Biophys. Res. Commun. 1996;229:287\u2013294. doi: 10.1006/bbrc.1996.1794.", "ArticleIdList": ["10.1006/bbrc.1996.1794", "8954120"]}, {"Citation": "Meng Y., Liu S., Li J., Meng Y., Zhao X. Preparation of an antitumor and antivirus agent: Chemical modification of \u03b1-MMC and MAP30 from Momordica charantia L. with covalent conjugation of polyethyelene glycol. Int. J. Nanomed. 2012;7:3133.", "ArticleIdList": ["PMC3396394", "22802682"]}, {"Citation": "Leung S.O., Yeung H.W., Leung K.N. The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia) Immunopharmacology. 1987;13:159\u2013171. doi: 10.1016/0162-3109(87)90054-3.", "ArticleIdList": ["10.1016/0162-3109(87)90054-3", "3497134"]}, {"Citation": "Jabeen U., Khanum A. Isolation and characterization of potential food preservative peptide from Momordica charantia L. Arab. J. Chem. 2017;10:S3982\u2013S3989. doi: 10.1016/j.arabjc.2014.06.009.", "ArticleIdList": ["10.1016/j.arabjc.2014.06.009"]}, {"Citation": "Fang E.F., Zhang C.Z.Y., Ng T.B., Wong J.H., Pan W.L., Ye X.J., Chan Y.S., Fong W.P. Momordica charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo. Cancer Prev. Res. 2012;5:109\u2013121. doi: 10.1158/1940-6207.CAPR-11-0203.", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0203", "21933914"]}, {"Citation": "Paul A., Raychaudhuri S.S. Medicinal uses and molecular identification of two Momordica charantia varieties\u2014A review. Electron. J. Biol. 2010;6:43\u201351."}, {"Citation": "Wang B.L., Zhang W., Zhao J., Wang F., Fan L., Hu Z. Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia. J. Sci. Food Agric. 2011;91:2443\u20132448. doi: 10.1002/jsfa.4485.", "ArticleIdList": ["10.1002/jsfa.4485", "21626510"]}, {"Citation": "Yuan X., Gu X., Tang J. Purification and characterisation of a hypoglycemic peptide from Momordica charantia L. Var. abbreviata Ser. Food Chem. 2008;111:415\u2013420. doi: 10.1016/j.foodchem.2008.04.006.", "ArticleIdList": ["10.1016/j.foodchem.2008.04.006", "26047444"]}, {"Citation": "Mahatmanto T. Review seed biopharmaceutical cyclic peptides: From discovery to applications. Pept. Sci. 2015;104:804\u2013814. doi: 10.1002/bip.22741.", "ArticleIdList": ["10.1002/bip.22741", "26385189"]}, {"Citation": "Zhang B., Xie C., Wei Y., Li J., Yang X. Purification and characterisation of an antifungal protein, MCha-Pr, from the intercellular fluid of bitter gourd (Momordica charantia) leaves. Protein Expr. Purif. 2015;107:43\u201349. doi: 10.1016/j.pep.2014.09.008.", "ArticleIdList": ["10.1016/j.pep.2014.09.008", "25245535"]}, {"Citation": "Altuhafi A., Altun M., Hadwan M.H. The Correlation between Selenium-Dependent Glutathione Peroxidase Activity and Oxidant/Antioxidant Balance in Sera of Diabetic Patients with Nephropathy. Rep. Biochem. Mol. Biol. 2021;10:164\u2013172. doi: 10.52547/rbmb.10.2.164.", "ArticleIdList": ["10.52547/rbmb.10.2.164", "PMC8480288", "34604406"]}, {"Citation": "Shi J., Arunasalam K., Yeung D., Kakuda Y., Mittal G., Jiang Y., Ercan P., El S.N., Kim J.E., Go J., et al. Saponins from edible legumes: Chemistry, processing, and health benefits. J. Med. Food. 2004;7:67\u201378. doi: 10.1089/109662004322984734.", "ArticleIdList": ["10.1089/109662004322984734", "15117556"]}, {"Citation": "Vincken J.P., Heng L., de Groot A., Gruppen H. Saponins, classification and occurrence in the plant kingdom. Phytochemistry. 2007;68:275\u2013297. doi: 10.1016/j.phytochem.2006.10.008.", "ArticleIdList": ["10.1016/j.phytochem.2006.10.008", "17141815"]}, {"Citation": "Chen J.C., Chiu M.H., Nie R.L., Cordell G.A., Qiu S.X. Cucurbitacins and cucurbitane glycosides: Structures and biological activities. Nat. Prod. Rep. 2005;22:386\u2013399. doi: 10.1039/b418841c.", "ArticleIdList": ["10.1039/b418841c", "16010347"]}, {"Citation": "Murakami T., Emoto A., Matsuda H., Yoshikawa M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a,-b,-c,-d,-e,-f,-g, and-h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem. Pharm. Bull. 2001;49:54\u201363. doi: 10.1248/cpb.49.54.", "ArticleIdList": ["10.1248/cpb.49.54", "11201226"]}, {"Citation": "Harinantenaina L., Tanaka M., Takaoka S., Oda M., Mogami O., Uchida M., Asakawa Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem. Pharm. Bull. 2006;54:1017\u20131021. doi: 10.1248/cpb.54.1017.", "ArticleIdList": ["10.1248/cpb.54.1017", "16819222"]}, {"Citation": "Tan M.J., Ye J.M., Turner N., Hohnen-Behrens C., Ke C.Q., Tang C.P., Chen T., Weiss H.-C., Gesing E.-R., Rowland A., et al. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol. 2008;15:263\u2013273. doi: 10.1016/j.chembiol.2008.01.013.", "ArticleIdList": ["10.1016/j.chembiol.2008.01.013", "18355726"]}, {"Citation": "Krawinkel M.B., Keding G.B. Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutr. Rev. 2006;64:331\u2013337. doi: 10.1111/j.1753-4887.2006.tb00217.x.", "ArticleIdList": ["10.1111/j.1753-4887.2006.tb00217.x", "16910221"]}, {"Citation": "Pitiphanpong J., Chitprasert S., Goto M., Jiratchariyakul W., Sasaki M., Shotipruk A. New approach for extraction of charantin from Momordica charantia with pressurized liquid extraction. Sep. Purif. Technol. 2007;52:416\u2013422. doi: 10.1016/j.seppur.2005.11.037.", "ArticleIdList": ["10.1016/j.seppur.2005.11.037"]}, {"Citation": "Patel S., Patel T., Parmar K., Bhatt Y., Patel Y., Patel N.M.D. Isolation, characterization and antimicrobial activity of charantin from Momordica charantia linn. Fruit. Int. J. Drug Dev. Res. 2010;2:629\u2013634."}, {"Citation": "Hollman P.C., de Vries J.H., van Leeuwen S.D., Mengelers M.J., Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995;62:1276\u20131282. doi: 10.1093/ajcn/62.6.1276.", "ArticleIdList": ["10.1093/ajcn/62.6.1276", "7491892"]}, {"Citation": "Haddad P.S., Eid H.M., Nachar A., Thong F., Sweeney G. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn. Mag. 2015;11:74\u201381. doi: 10.4103/0973-1296.149708.", "ArticleIdList": ["10.4103/0973-1296.149708", "PMC4329636", "25709214"]}, {"Citation": "Youl E., Bardy G., Magous R., Cros G., Sejalon F., Virsolvy A., Richard S., Quignard J.F., Gross R., Petit P., et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic \u03b2-cells against oxidative damage via the ERK1/2 pathway. Br. J. Pharmacol. 2010;161:799\u2013814. doi: 10.1111/j.1476-5381.2010.00910.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00910.x", "PMC2992896", "20860660"]}, {"Citation": "Peng J., Li Q., Li K., Zhu L., Lin X., Lin X., Shen Q., Li G., Xie X. Quercetin improves glucose and lipid metabolism of diabetic rats: Involvement of Akt signaling and SIRT1. J. Diabetes Res. 2017;2017:3417306. doi: 10.1155/2017/3417306.", "ArticleIdList": ["10.1155/2017/3417306", "PMC5742905", "29379801"]}, {"Citation": "Eid H.M., Haddad P.S. The Antidiabetic Potential of Quercetin: Underlying Mechanisms. Curr. Med. Chem. 2017;24:355\u2013364.", "ArticleIdList": ["27633685"]}, {"Citation": "Ergul A. Endothelin-1 and diabetic complications: Focus on the vasculature. Pharmacol. Res. 2011;63:477\u2013482. doi: 10.1016/j.phrs.2011.01.012.", "ArticleIdList": ["10.1016/j.phrs.2011.01.012", "PMC7383935", "21292003"]}, {"Citation": "Qu L., Liang X., Gu B., Liu W. Quercetin alleviates high glucose-induced Schwann cell damage by autophagy. Neural Regen. Res. 2014;9:1195\u20131203. doi: 10.4103/1673-5374.135328.", "ArticleIdList": ["10.4103/1673-5374.135328", "PMC4146282", "25206782"]}, {"Citation": "Xia S.-F., Xie Z.-X., Qiao Y., Li L.-R., Cheng X.-R., Tang X., Shi Y.-H., Le G.-W. Differential effects of quercetin on hippocampus-dependent learning and memory in mice fed with different diets related with oxidative stress. Physiol. Behav. 2015;138:325\u2013331. doi: 10.1016/j.physbeh.2014.09.008.", "ArticleIdList": ["10.1016/j.physbeh.2014.09.008", "25447470"]}, {"Citation": "Zhu X., Cheng Y.-Q., Lu Q., Du L., Yin X.-X., Liu Y.-W. Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2018;391:1237\u20131245. doi: 10.1007/s00210-018-1543-z.", "ArticleIdList": ["10.1007/s00210-018-1543-z", "30062553"]}, {"Citation": "Ansari M.A., Abdul H.M., Joshi G., Opii W.O., Butterfield D.A. Protective effect of quercetin in primary neurons against A\u0392(1\u201342): Relevance to Alzheimer\u2019s disease. J. Nutr. Biochem. 2009;20:269\u2013275. doi: 10.1016/j.jnutbio.2008.03.002.", "ArticleIdList": ["10.1016/j.jnutbio.2008.03.002", "PMC2737260", "18602817"]}, {"Citation": "Kong Y., Li K., Fu T., Wan C., Zhang D., Song H., Zhang Y., Liu N., Gan Z., Yuan L. Quercetin ameliorates A\u0392 toxicity in drosophila AD model by modulating cell cycle-related protein expression. Oncotarget. 2016;7:67716\u201367731. doi: 10.18632/oncotarget.11963.", "ArticleIdList": ["10.18632/oncotarget.11963", "PMC5356514", "27626494"]}, {"Citation": "Sabogal-Gu\u00e1queta A.M., Mu\u00f1oz-Manco J.I., Ram\u00edrez-Pineda J.R., Lamprea-Rodriguez M., Osorio E., Cardona-G\u00f3mez G.P. The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice. Neuropharmacology. 2015;93:134\u2013145. doi: 10.1016/j.neuropharm.2015.01.027.", "ArticleIdList": ["10.1016/j.neuropharm.2015.01.027", "PMC4387064", "25666032"]}, {"Citation": "Wang D.-M., Li S.-Q., Wu W.-L., Zhu X.-Y., Wang Y., Yuan H.-Y. Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer\u2019s disease. Neurochem. Res. 2014;39:1533\u20131543. doi: 10.1007/s11064-014-1343-x.", "ArticleIdList": ["10.1007/s11064-014-1343-x", "24893798"]}, {"Citation": "Vargas-Restrepo F., Sabogal-Gu\u00e1queta A.M., Cardona-G\u00f3mez G.P. Quercetin ameliorates inflammation in CA1 hippocampal region in aged triple transgenic Alzheimer\u2019s disease mice model. Biom\u00e9dica. 2017;38:69\u201376. doi: 10.7705/biomedica.v38i0.3761.", "ArticleIdList": ["10.7705/biomedica.v38i0.3761", "29809330"]}, {"Citation": "Yang J., Guo J., Yuan J. In vitro antioxidant properties of Rutin. LWT-Food Sci. Technol. 2008;41:1060\u20131066. doi: 10.1016/j.lwt.2007.06.010.", "ArticleIdList": ["10.1016/j.lwt.2007.06.010"]}, {"Citation": "Ghorbani A. Mechanisms of antidiabetic effects of flavonoid Rutin. Biomed. Pharmacother. 2017;96:305\u2013312. doi: 10.1016/j.biopha.2017.10.001.", "ArticleIdList": ["10.1016/j.biopha.2017.10.001", "29017142"]}, {"Citation": "Ahmed O.M., Moneim A.A., Yazid I.A., and Mahmoud A.M. Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin- induced diabetic rats. Diabetol. Croat. 2010;39:15\u201335."}, {"Citation": "Wang S.W., Wang Y.J., Su Y.J., Zhou W.W., Yang S.G., Zhang R., Zhao M., Li Y.N., Zhang Z.P., Zhan D.W., et al. Rutin inhibits \u03b2-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and pro-inflammatory cytokines. Neurotoxicology. 2012;33:482\u2013490. doi: 10.1016/j.neuro.2012.03.003.", "ArticleIdList": ["10.1016/j.neuro.2012.03.003", "22445961"]}, {"Citation": "Hevener A.L., He W., Barak Y., Le J., Bandyopadhyay G., Olson P., Wilkes J., Evans R.M., Olefsky J. Muscle-specific PPARG deletion causes insulin resistance. Nat. Med. 2003;9:1491\u20131497. doi: 10.1038/nm956.", "ArticleIdList": ["10.1038/nm956", "14625542"]}, {"Citation": "Cai E.P., Lin J.-K. Epigallocatechin gallate (EGCG) and Rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic \u03b2 cells. J. Agric. Food Chem. 2009;57:9817\u20139827. doi: 10.1021/jf902618v.", "ArticleIdList": ["10.1021/jf902618v", "19803520"]}, {"Citation": "Niture N.T., Ansari A.A., Naik S.R. Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines, antioxidants and lipid biomarkers. Indian J. Exp. Biol. 2014;52:720\u2013727.", "ArticleIdList": ["25059040"]}, {"Citation": "Habtemariam S. Rutin as a natural therapy for Alzheimer\u2019s disease: Insights into its mechanisms of action. Curr. Med. Chem. 2016;23:860\u2013873. doi: 10.2174/0929867323666160217124333.", "ArticleIdList": ["10.2174/0929867323666160217124333", "26898570"]}, {"Citation": "Jim\u00e9nez-Aliaga K., Bermejo-Besc\u00f3s P., Bened\u00ed J., Mart\u00edn-Arag\u00f3n S. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci. 2011;89:939\u2013945. doi: 10.1016/j.lfs.2011.09.023.", "ArticleIdList": ["10.1016/j.lfs.2011.09.023", "22008478"]}, {"Citation": "Moghbelinejad S., Nassiri-Asl M., Farivar T.N., Abbasi E., Sheikhi M., Taghiloo M., Farsad F., Samimi A., Hajiali F. Rutin activates the MAPK pathway and BDNF gene expression on beta-amyloid induced neurotoxicity in rats. Toxicol. Lett. 2014;224:108\u2013113. doi: 10.1016/j.toxlet.2013.10.010.", "ArticleIdList": ["10.1016/j.toxlet.2013.10.010", "24148604"]}, {"Citation": "Choi J.Y., Lee J.M., Lee D.G., Cho S., Yoon Y.-H., Cho E.J., Lee S. The n-butanol fraction and rutin from Tartary buckwheat improve cognition and memory in an in vivo model of amyloid-\u03b2-induced Alzheimer\u2019s disease. J. Med. Food. 2015;18:631\u2013641. doi: 10.1089/jmf.2014.3292.", "ArticleIdList": ["10.1089/jmf.2014.3292", "25785882"]}, {"Citation": "Al-Ishaq R.K., Abotaleb M., Kubatka P., Kajo K., B\u00fcsselberg D. Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels. Biomolecules. 2019;9:430. doi: 10.3390/biom9090430.", "ArticleIdList": ["10.3390/biom9090430", "PMC6769509", "31480505"]}, {"Citation": "Calderon-Montano J.M., Burgos-Moron E., Perez-Guerrero C., Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini Rev. Med. Chem. 2011;11:298\u2013344. doi: 10.2174/138955711795305335.", "ArticleIdList": ["10.2174/138955711795305335", "21428901"]}, {"Citation": "Zhang Z., Ding Y., Dai X., Wang J., Li Y. Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur. J. Pharmacol. 2011;670:311\u2013316. doi: 10.1016/j.ejphar.2011.08.033.", "ArticleIdList": ["10.1016/j.ejphar.2011.08.033", "21925162"]}, {"Citation": "Zhang Y., Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur. J. Pharmacol. 2011;670:325\u2013332. doi: 10.1016/j.ejphar.2011.08.011.", "ArticleIdList": ["10.1016/j.ejphar.2011.08.011", "21914439"]}, {"Citation": "Alkhalidy H., Moore W., Wang Y., Luo J., McMillan R.P., Zhen W., Zhou K., Liu D. The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production. Molecules. 2018;23:2338. doi: 10.3390/molecules23092338.", "ArticleIdList": ["10.3390/molecules23092338", "PMC6192519", "30216981"]}, {"Citation": "Sharma D., Gondaliya P., Tiwari V., Kalia K. Kaempferol attenuates diabetic nephropathy by inhibiting RhoA/Rho-kinase mediated inflammatory signaling. Biomed. Pharmacother. 2019;109:1610\u20131619. doi: 10.1016/j.biopha.2018.10.195.", "ArticleIdList": ["10.1016/j.biopha.2018.10.195", "30551415"]}, {"Citation": "Vinayagam R., Xu B. Antidiabetic properties of dietary flavonoids: A cellular mechanism review. Nutr. Metab. 2015;12:60. doi: 10.1186/s12986-015-0057-7.", "ArticleIdList": ["10.1186/s12986-015-0057-7", "PMC4690284", "26705405"]}, {"Citation": "Lee Y.S., Lee S., Lee H.S., Kim B.K., Ohuchi K., Shin K.H. Inhibitory effects of isorhamnetin-3-O-beta-D-glucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. Biol. Pharm. Bull. 2005;28:916\u2013918. doi: 10.1248/bpb.28.916.", "ArticleIdList": ["10.1248/bpb.28.916", "15863906"]}, {"Citation": "Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: Chemistry, bioavailability and effects on health. Nat. Prod. Rep. 2009;26:1001\u20131043. doi: 10.1039/b802662a.", "ArticleIdList": ["10.1039/b802662a", "19636448"]}, {"Citation": "Zhang F., Lin L., Xie J. A mini-review of chemical and biological properties of polysaccharides from Momordica charantia. Int. J. Biol. Macromol. 2016;92:246\u2013253. doi: 10.1016/j.ijbiomac.2016.06.101.", "ArticleIdList": ["10.1016/j.ijbiomac.2016.06.101", "27377459"]}, {"Citation": "Deng Y.Y., Yi Y., Zhang L.F., Zhang R.F., Zhang Y., Wei Z.C., Zhang M.W. Immunomodulatory activity and partial characterization of polysaccharides from Momordica charantia. Molecules. 2014;19:13432\u201313447. doi: 10.3390/molecules190913432.", "ArticleIdList": ["10.3390/molecules190913432", "PMC6271773", "25178064"]}, {"Citation": "Duan Z.Z., Zhou X.L., Li Y.H., Zhang F., Li F.Y., Su-Hua Q. Protection of Momordica charantia polysaccharide against intracerebral hemorrhage-induced brain injury through JNK3 signaling pathway. J. Recept. Signal Transduct. 2015;35:523\u2013529. doi: 10.3109/10799893.2014.963871.", "ArticleIdList": ["10.3109/10799893.2014.963871", "25264226"]}, {"Citation": "Cai Y., Liu M., Wu X., Wang Z., Liang C., Yang Y. Study on the antitumor and immune-stimulating activity of polysaccharide from Momordica charantia. Pharm. Clin. Res. 2010;18:131\u2013134."}, {"Citation": "Zhang P.P., Liu J.F., Wang C.L., Ye Y.T., Xie J.H. Study on the antimicrobial activities of the extracts from Momordica charantia L. Nat. Prod. Res. 2008;20:721\u2013724."}, {"Citation": "Panda B.C., Mondal S., Devi K.S.P., Maiti T.K., Khatua S., Acharya K., Islam S.S. Pectic polysaccharide from the green fruits of Momordica charantia (Karela): Structural characterization and study of immunoenhancing and antioxidant properties. Carbohydr. Res. 2015;401:24\u201331. doi: 10.1016/j.carres.2014.10.015.", "ArticleIdList": ["10.1016/j.carres.2014.10.015", "25464078"]}, {"Citation": "Dong Y., Xu B., Lu Q., Zha Q. Studies on the Isolation, Purification and Composition of Momordica charantia L. Polysaccharide. Food Sci. 2005;11:023."}, {"Citation": "Fan T., Hu J., Fu L., Zhang L. Optimization of enzymolysis-ultrasonic assisted extraction of polysaccharides from Momordica charantia L. by response surface methodology. Carbohydr. Polym. 2015;115:701\u2013706. doi: 10.1016/j.carbpol.2014.09.009.", "ArticleIdList": ["10.1016/j.carbpol.2014.09.009", "25439951"]}, {"Citation": "Tan H.F., Gan C.Y. Polysaccharide with antioxidant, \u03b1-amylase inhibitory and ACE inhibitory activities from Momordica charantia. Int. J. Biol. Macromol. 2016;85:487\u2013496. doi: 10.1016/j.ijbiomac.2016.01.023.", "ArticleIdList": ["10.1016/j.ijbiomac.2016.01.023", "26778156"]}, {"Citation": "Xu X., Shan B., Liao C.H., Xie J.H., Wen P.W., Shi J.Y. Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice. Int. J. Biol. Macromol. 2015;81:538\u2013543. doi: 10.1016/j.ijbiomac.2015.08.049.", "ArticleIdList": ["10.1016/j.ijbiomac.2015.08.049", "26318666"]}, {"Citation": "Barrett M.L., Udani J.K. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): A review of clinical studies on weight loss and glycemic control. Nutr. J. 2011;10:24. doi: 10.1186/1475-2891-10-24.", "ArticleIdList": ["10.1186/1475-2891-10-24", "PMC3071778", "21414227"]}, {"Citation": "Hypoglycemia (Low Blood Glucose)  Hypoglycemia (Low Blood Glucose)|ADA. (n.d.)  [(accessed on 15 October 2022)].  Available online:  https://diabetes.org/healthy-living/medication-treatments/blood-glucose-testing-and-control/hypoglycemia."}, {"Citation": "Raish M. Momordica charantia, polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the nf-kb signaling pathway. Int. J. Biol. Macromol. 2017;97:544\u2013551. doi: 10.1016/j.ijbiomac.2017.01.074.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.01.074", "28109806"]}, {"Citation": "Liu T., Zhang L., Joo D., Sun S.-C. NF-\u03baB signaling in inflammation. Signal Transduct. Target. Ther. 2017;2:17023. doi: 10.1038/sigtrans.2017.23.", "ArticleIdList": ["10.1038/sigtrans.2017.23", "PMC5661633", "29158945"]}, {"Citation": "Kang J., Zeng B., Tang S., Wang M., Han X., Zhou C., Tan Z. Effects of Momordica charantia polysaccharide on in vitro ruminal fermentation and cellulolytic bacteria. Ital. J. Anim. Sci. 2017;16:226\u2013233. doi: 10.1080/1828051X.2017.1289825.", "ArticleIdList": ["10.1080/1828051X.2017.1289825"]}, {"Citation": "Kumar D.S., Sharathnath V.K., Yogeswaran P., Harani A., Sudhakar K., Sudha P., Banji D. A medicinal potency of Momordica charantia. Int. J. Pharm Sci Rev Res. 2010;1:95\u201399."}, {"Citation": "Hazarika R., Parida P., Neog B., Yadav R.N.S. Binding energy calculation of GSK-3 protein of human against some anti- diabetic compounds of Momordica charantia linn (Bitter melon) Bioinformation. 2012;8:251\u2013254. doi: 10.6026/97320630008251.", "ArticleIdList": ["10.6026/97320630008251", "PMC3321233", "22493531"]}, {"Citation": "Leclerc M., Dudonn\u00e9 S., Calon F. Can Natural Products Exert Neuroprotection without Crossing the Blood\u2013Brain Barrier? Int. J. Mol. Sci. 2021;22:3356. doi: 10.3390/ijms22073356.", "ArticleIdList": ["10.3390/ijms22073356", "PMC8037419", "33805947"]}, {"Citation": "Shan B., Xie J.H., Zhu J.H., Peng Y. Ethanol modified supercritical carbon dioxide extraction of flavonoids from Momordica charantia L. and its antioxidant activity. Food Bioprod. Process. 2012;90:579\u2013587. doi: 10.1016/j.fbp.2011.09.004.", "ArticleIdList": ["10.1016/j.fbp.2011.09.004"]}, {"Citation": "Tan S.P., Stathopoulos C., Parks S., Roach P. An optimised aqueous extract of phenolic compounds from bitter melon with high antioxidant capacity. Antioxidants. 2014;3:814\u2013829. doi: 10.3390/antiox3040814.", "ArticleIdList": ["10.3390/antiox3040814", "PMC4665506", "26785242"]}, {"Citation": "Abotaleb M., Samuel S.M., Varghese E., Varghese S., Kubatka P., Liskova A., Busselberg D. Flavonoids in Cancer and Apoptosis. Cancers. 2018;11:28. doi: 10.3390/cancers11010028.", "ArticleIdList": ["10.3390/cancers11010028", "PMC6357032", "30597838"]}, {"Citation": "Madala N.E., Piater L., Dubery I., Steenkamp P. Distribution patterns of flavonoids from three momordica species by ultra-high performance liquid chromatography quadrupole time of flight mass spectrometry: A metabolomic profiling approach. Rev. Bras. De Farmacogn. 2016;26:507\u2013513. doi: 10.1016/j.bjp.2016.03.009.", "ArticleIdList": ["10.1016/j.bjp.2016.03.009"]}, {"Citation": "Chuang C.Y., Hsu C., Chao C.Y., Wein Y.S., Kuo Y.H., Huang C.J. Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPAR\u03b1 in bitter gourd (Momordica charantia L.) J. Biomed. Sci. 2006;13:763\u2013772. doi: 10.1007/s11373-006-9109-3.", "ArticleIdList": ["10.1007/s11373-006-9109-3", "16955349"]}, {"Citation": "Lucas E.A., Dumancas G.G., Smith B.J., Clarke S.L., Arjmandi B.H. Health benefits of bitter melon (Momordica charantia) Bioact. Foods Promot. Health. 2010;35:525\u2013549."}, {"Citation": "Yuwai K.E., Rao K.S., Kaluwin C., Jones G.P., Rivett D.E. Chemical composition of Momordica charantia L. fruits. J. Agric. Food Chem. 1991;39:1762\u20131763. doi: 10.1021/jf00010a013.", "ArticleIdList": ["10.1021/jf00010a013"]}, {"Citation": "Kenny O., Smyth T.J., Hewage C.M., Brunton N.P. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit. Food Chem. 2013;141:4295\u20134302. doi: 10.1016/j.foodchem.2013.07.016.", "ArticleIdList": ["10.1016/j.foodchem.2013.07.016", "23993618"]}, {"Citation": "Ke L.J., Lu W., Chang J.L., Yuan F.Y., Rao P.F., Zhou J.W. Effects of heat drying process on amino acid content of Momordica charantia L. Amino Acids Biol. Resour. 2010;32:14\u201316."}, {"Citation": "Han C., Zuo J., Wang Q., Xu L., Wang Z., Dong H., Gao L. Effects of 1-MCP on postharvest physiology and quality of bitter melon (Momordica charantia L.) Sci. Hortic-Ansterdam. 2015;182:86\u201391. doi: 10.1016/j.scienta.2014.07.024.", "ArticleIdList": ["10.1016/j.scienta.2014.07.024"]}, {"Citation": "Shi L., Du X., Guo P., Huang L., Qi P., Gong Q. Ascorbic acid supplementation in type 2 diabetes mellitus: A protocol for systematic review and meta-analysis. Medicine. 2020;99:e23125. doi: 10.1097/MD.0000000000023125.", "ArticleIdList": ["10.1097/MD.0000000000023125", "PMC7647560", "33157992"]}, {"Citation": "Taylor L. Bitter melon (Momordica charantia) In: Texas A., editor. Herbal Secrets of the Rainforest. 2nd ed. Sage Press; Thousand Oaks, CA, USA: 2002. pp. 1\u2013100."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "1"}, {"Year": "2023", "Month": "2", "Day": "21"}, {"Year": "2023", "Month": "2", "Day": "23"}, {"Year": "2023", "Month": "3", "Day": "11", "Hour": "1", "Minute": "17"}, {"Year": "2023", "Month": "3", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["36902074", "PMC10002567", "10.3390/ijms24054643", "ijms24054643"]}}], "PubmedBookArticle": []}